|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.64 USD | -2.33% |
|
-3.24% | +15.82% |
| Capitalization | 2.4B 2.05B 1.9B 1.78B 3.32B 219B 3.56B 21.9B 8.65B 104B 9.01B 8.82B 379B | P/E ratio 2025 * |
-32.7x | P/E ratio 2026 * | -115x |
|---|---|---|---|---|---|
| Enterprise value | 2.84B 2.42B 2.25B 2.11B 3.93B 259B 4.22B 25.93B 10.24B 123B 10.67B 10.45B 449B | EV / Sales 2025 * |
0.49x | EV / Sales 2026 * | 0.48x |
| Free-Float |
97.42% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: RXO, Inc.
| 1 day | -2.33% | ||
| 1 week | -3.24% | ||
| Current month | +15.82% | ||
| 1 month | +7.96% | ||
| 3 months | -19.34% | ||
| 6 months | -9.46% | ||
| Current year | +15.82% |
| 1 week | 14.35 |  | 15.67 |
| 1 month | 12.33 | | 15.67 |
| Current year | 12.49 | | 15.67 |
| 1 year | 10.42 | | 26.92 |
| 3 years | 10.42 | | 32.82 |
| 5 years | 10.42 | | 32.82 |
| 10 years | 10.42 | | 32.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Wilkerson
CEO | Chief Executive Officer | 42 | 2022-10-16 |
James Harris
DFI | Director of Finance/CFO | 64 | - |
Yoav Amiel
CTO | Chief Tech/Sci/R&D Officer | - | 2022-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Tom Szlosek
BRD | Director/Board Member | 62 | 2022-10-31 |
Adrian Kingshott
BRD | Director/Board Member | 66 | 2022-10-31 |
Troy Cooper
BRD | Director/Board Member | 56 | 2024-06-09 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -3.24% | -41.93% | -13.42% | 2.46B | |
| -3.22% | -0.96% | -10.31% | +7.25% | 36.73B | |
| -0.43% | -0.81% | +18.01% | +7.62% | 19.33B | |
| -2.88% | -4.42% | -30.00% | +36.91% | 9.32B | |
| -3.75% | -2.95% | -22.52% | +4.14% | 9.27B | |
| -1.60% | -1.59% | -13.28% | -10.24% | 5.27B | |
| -0.44% | +2.79% | +77.73% | +206.15% | 2.66B | |
| -2.75% | -2.98% | -11.70% | -28.55% | 1.98B | |
| -1.29% | -3.47% | -5.99% | +30.07% | 1.81B | |
| -0.08% | +0.08% | +78.38% | +160.86% | 1.84B | |
| Average | -1.88% | -0.40% | +3.84% | +40.08% | 9.07B | |
| Weighted average by Cap. | -2.33% | -0.09% | -4.15% | +17.10% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.76B 4.91B 4.55B 4.28B 7.97B 525B 8.55B 52.54B 20.76B 249B 21.62B 21.17B 910B | 5.95B 5.07B 4.7B 4.42B 8.23B 542B 8.83B 54.25B 21.43B 258B 22.32B 21.86B 940B |
| Net income | -75.25M -64.14M -59.43M -55.89M -104M -6.85B -112M -686M -271M -3.26B -282M -276M -11.88B | -21.13M -18.01M -16.69M -15.69M -29.21M -1.92B -31.33M -193M -76.1M -914M -79.24M -77.62M -3.34B |
| Net Debt | 442M 377M 349M 328M 611M 40.22B 655M 4.03B 1.59B 19.12B 1.66B 1.62B 69.79B | 448M 382M 354M 333M 619M 40.75B 664M 4.08B 1.61B 19.38B 1.68B 1.64B 70.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-20 | 14.64 $ | -2.33% | 1,393,093 |
| 26-01-16 | 14.99 $ | -3.79% | 1,255,169 |
| 26-01-15 | 15.58 $ | +2.43% | 1,537,351 |
| 26-01-14 | 15.21 $ | +0.53% | 3,163,857 |
| 26-01-13 | 15.13 $ | +2.58% | 3,204,315 |
Delayed Quote Nyse, January 20, 2026 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RXO Stock
Select your edition
All financial news and data tailored to specific country editions
